Representatives of Harvard Medical School and Semmelweis University signed a cooperation agreement last December on a postgraduate training program starting on 17 July 2023 and running until June 2026, for which registration is now open. The training, which primarily focuses on health research and methods, is open to young clinicians, PhD students, postdoctoral fellows and residents who have a background in science and are interested in developing their competencies in clinical trials.
Dr. Béla Merkely, Rector of Semmelweis University, pointed out that the program provides a unique opportunity for young people, and the knowledge acquired through the project will serve them throughout their clinical careers.
The training is primarily aimed at postdocs and those who have already gained research experience in the first two years of their PhD or in their research studentships – they are the ones who will benefit most from the knowledge that Harvard and Semmelweis University have to offer
– he pointed out, adding that it is essential that candidates imagine their future in the clinical field, as the training focuses on clinical research. “The scope of the program is very broad: from epidemiology to the design and implementation of investigator-initiated trials, it covers the most important aspects of clinical trials, from hypothesis generation to data recording and evaluation as well as biostatistics. All this is done with a practical approach, focusing on clinically relevant solutions, through seminar presentations, individual and small-group work and online classes,” said the rector.
To read the full article click HERE!
